Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

PSA can help diagnose high androgen levels in women.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Chemotherapy caused a woman's permanent hair loss and early menopause.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

A new gene, JMJD1C, may affect testosterone levels in men.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

The removed ovarian tumor was a rare type of blood vessel tumor that improved the patient's symptoms and hormone levels after surgery.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

Female hair loss is often hereditary and can be treated with medication, hair transplants, and lasers.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.